One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings.
We present a case history involving one fatal and seven survived cases of intoxication with 4-methylthioamphetamine (4-MTA), also called para-methylthioamphetamine (p-MTA) or methylthioamphetamine (MTA), a relatively new amphetamine analogue. Two of the seven survivors required a 24-h-period of observation in hospital. This report proves once again that the new amphetamine designer drugs are not without danger, as is thought by many young people. In addition, individually different subjective reactions are described. Finally, the medico-legal implications of new, as yet unregistered drugs are discussed.
De Letter
E A
EA
Department of Forensic Medicine, Ghent University, Belgium.
Coopman
V A
VA
Cordonnier
J A
JA
Piette
M H
MH
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000378:metabolism / Q000506:poisoning*; D015198:Designer Drugs / Q000378:metabolism / Q000506:poisoning*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D014179:Neurotransmitter Uptake Inhibitors / Q000378:metabolism / Q000506:poisoning*; D011041:Poisoning / Q000097:blood / Q000652:urine; D017367:Selective Serotonin Reuptake Inhibitors / Q000506:poisoning
D000662:Amphetamines; D015198:Designer Drugs; D014179:Neurotransmitter Uptake Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; C078956:4-methylthioamphetamine